Ashwin Sachdeva

Ashwin Sachdeva is a Clinical Senior Lecturer in Urology at the Division of Cancer Sciences, University of Manchester. His research focuses on prostate cancer, clinical trials, translational research, and cancer metabolism. He has contributed to major studies like the STAMPEDE trial, investigating treatments for metastatic prostate cancer. His work aligns with UN Sustainable Development Goals related to health and well-being.

Education: BMed and BSurg from Newcastle University; PhD on mitochondrial alterations in prostate cancer progression; MSc in Interdisciplinary Medicine & Engineering from the University of Manchester. Professional qualifications include The Royal College of Surgeons of England membership.

Research interests include androgen deprivation therapy, novel hormonal therapies, and biomarker development. He has authored over 50 peer-reviewed articles, with recent work addressing cardiovascular risks of androgen receptor inhibitors and penile cancer management guidelines.

Awards include the 2022 Prostate Cancer Foundation Young Investigator Award, 2024 European Urology Impact Award, and 2015 The Urology Foundation Research Scholarship Medal. He actively contributes to clinical trials, guideline development, and media discussions on prostate cancer advancements.

Labs/Teams: Involved with Manchester Cancer Research Centre and Cancer Digital Futures initiatives. Collaborates internationally on oncology research and clinical trials.